ptaquiloside has been researched along with Experimental Mammary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aiso, S; Hirono, I; Kigoshi, H; Mori, H; Niiyama, K; Niwa, H; Ojika, M; Wakamatsu, K; Yamada, K; Yamaji, T | 1 |
| Moore, MR; Prakash, AS; Seawright, AA; Shahin, M; Smith, BL; Worral, S | 1 |
2 other study(ies) available for ptaquiloside and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Carcinogenicity in rats of ptaquiloside isolated from bracken.
Topics: Animals; Carcinogens; Female; Ileal Neoplasms; Indans; Mammary Neoplasms, Experimental; Plants; Rats; Rats, Inbred Strains; Sesquiterpenes; Terpenes | 1984 |
Bracken fern carcinogenesis: multiple intravenous doses of activated ptaquiloside induce DNA adducts, monocytosis, increased TNF alpha levels, and mammary gland carcinoma in rats.
Topics: Adenocarcinoma; Animals; Carcinogens; DNA Adducts; Drug Administration Schedule; Female; Indans; Injections, Intravenous; Leukocyte Count; Leukocytosis; Mammary Neoplasms, Experimental; Monocytes; Plants, Toxic; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Terpenes; Tumor Necrosis Factor-alpha | 1998 |